Dr. Sandra Aliberti graduated from the University of Turin with a degree in Medicine and Surgery and later completed her residency in Oncology at the same university.
Over the years, she has served as a professional between INOC – Istituto Nazionale Oncologico Candiolo (since 2005) and Umberto I Hospital in Turin (years 2007-2009).
Since 2010 she has been working as a Medical Director at INOC – Istituto Nazionale Oncologico Candiolo, where she is among the members of the Oncology team. She is and has been Investigator and subinvestigator of several phase I, II, III clinical trials in the field of soft tissue and bone sarcomas.
She is a member of the Italian Sarcoma Group (ISG), AIOM and has participated in the activities required by the EURACAN-sarcoma domain.
She is the author and coauthor of about 35 scientific publications, has participated in numerous congresses, sometimes as a speaker particularly on the topic of bone and soft tissue sarcomas; has drafted consensus documents with working group of the Piedmont and Aosta Valley Oncology Network.